Parathyroid diseases and animal models

Parathyroid diseases and animal models

Circulating calcium and phosphate are tightly regulated by 3 hormones: the active form of vitamin D (1,25-dihydroxyvitamin D), fibroblast growth factor (FGF)-23, and parathyroid hormone (PTH). PTH acts to stimulate a rapid increment in serum calcium and has a crucial role in calcium homeostasis. Maj...

Full description

Bibliographic Details
Main Authors:	Yasuo eImanishi, Yuki eNagata, Masaaki eInaba
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2012-06-01
Series:	Frontiers in Endocrinology
Subjects:	Calcium Hypercalcemia Vitamin D Phosphate CKD FGF-23
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00078/full

Similar Items

Risk factors associated with disturbances of calcium homeostasis after initiation of a phosphate‐restricted diet in cats with chronic kidney disease
by: Pak‐Kan Tang, et al.
Published: (2021-01-01)

Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease
by: Teodora V. Grigore, et al.
Published: (2023-01-01)

Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients
by: Kanda Eiichiro, et al.
Published: (2012-09-01)

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
by: Matthew J. Damasiewicz, et al.
Published: (2018-11-01)

Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
by: Megan L. Noonan, et al.
Published: (2020-06-01)

Development of experimental chronic kidney disease and vascular calcification alters diurnal variation of phosphate and its hormonal regulators
by: Bruno A. Svajger, et al.
Published: (2020-11-01)

Memo1 gene expression in kidney and bone is unaffected by dietary mineral load and calciotropic hormones
by: Matthias B. Moor, et al.
Published: (2020-04-01)

Assessment of Inorganic Phosphate Intake by the Measurement of the Phosphate/Urea Nitrogen Ratio in Urine
by: María Victoria Pendón-Ruiz de Mier, et al.
Published: (2021-01-01)

The Importance of Phosphate Control in Chronic Kidney Disease
by: Ken Tsuchiya, et al.
Published: (2021-05-01)

Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort
by: Vervloet Marc G, et al.
Published: (2012-04-01)

The Increase in FGF23 Induced by Calcium Is Partially Dependent on Vitamin D Signaling
by: Sandra Rayego-Mateos, et al.
Published: (2022-06-01)

X-linked hypophosphatemic rickets: an Italian experts’ opinion survey
by: F. Emma, et al.
Published: (2019-05-01)

FGF23 level in poultry chicken, a systematic review and meta-analysis
by: Hossein Poorhemati, et al.
Published: (2023-10-01)

The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2022-12-01)

Osteomalacia in Adults: A Practical Insight for Clinicians
by: Luis Arboleya, et al.
Published: (2023-04-01)

Effects of Aldosterone, Osteoprotegerin and Fibroblast Growth Factor-23 and Some Biochemical Markers in Chronic Kidney Disease Patients (Stage II-IV) among Patients with or without Cardiovascular Events
by: Zeyad A. Ameen, et al.
Published: (2018-12-01)

Editorial: Management of osteoporosis in patients with chronic kidney disease
by: Mohamed Abdalbary, et al.
Published: (2023-01-01)

Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease
by: Helen V. Alderson, et al.
Published: (2021-10-01)

Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients
by: Ahmed Fayed, et al.
Published: (2018-10-01)

Upstream Regulators of Fibroblast Growth Factor 23
by: Danielle M. A. Ratsma, et al.
Published: (2021-02-01)

MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD
by: Deborah Mattinzoli, et al.
Published: (2022-11-01)

A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
by: Yinghui Lu, et al.
Published: (2023-04-01)

Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
by: Hisato Shima, et al.
Published: (2018-06-01)

Bone and bone derived factors in kidney disease
by: Petra Simic, et al.
Published: (2024-03-01)

Protective Role of Vitamin D in Renal Tubulopathies
by: Guido Gembillo, et al.
Published: (2020-03-01)

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
by: Bleskestad Inger H, et al.
Published: (2012-06-01)

Effects of different training modalities on phosphate homeostasis and local vitamin D metabolism in rat bone
by: Joost Buskermolen, et al.
Published: (2019-01-01)

Risk factors and implications associated with renal mineralization in chronic kidney disease in cats
by: Pak‐Kan Tang, et al.
Published: (2022-03-01)

Metabolic Imbalances and Bone Remodeling Agents in Adolescent Idiopathic Scoliosis: A Study in Postmenarcheal Girls
by: Anna Danielewicz, et al.
Published: (2023-08-01)

Serum vitamin D receptor and fibroblast growth factor-23 levels in postmenopausal primary knee osteoarthritis patients
by: Yağmur Tekeli Feyza, et al.
Published: (2022-10-01)

FGF23: From academic nephrology to personalized patients’ care
by: María Luisa González-Casaus, et al.
Published: (2021-05-01)

Differential diagnosis of hypercalcemia in a patient with CKD G5D
by: A. K. Eremkina, et al.
Published: (2022-02-01)

Optimization of bone health in children before and after renal transplantation: current perspectives and future directions
by: Kristen eSgambat, et al.
Published: (2014-02-01)

Effect of Carbon Monoxide Donor CORM-2 on Vitamin D3 Metabolism
by: Martina Feger, et al.
Published: (2013-11-01)

Renal Memo1 Differentially Regulates the Expression of Vitamin D-Dependent Distal Renal Tubular Calcium Transporters
by: Matthias B. Moor, et al.
Published: (2018-07-01)

The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23
by: José Alberto Navarro-García, et al.
Published: (2022-01-01)

Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23
by: Oscar D. Pons-Belda, et al.
Published: (2023-04-01)

Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease
by: Tally Naveh-Many, et al.
Published: (2020-06-01)

Complications and Treatments in Adult X-Linked Hypophosphatemia
by: Yasuo Imanishi, et al.
Published: (2022-09-01)

Acute High Dietary Phosphorus Following Low‐Phosphorus Diet Acclimation Does Not Enhance Intestinal Fractional Phosphorus Absorption in Nephrectomized Male Rats
by: Kendal M Burstad, et al.
Published: (2022-12-01)